in vivo gene editing program targeting lipoprotein(a) (Verve Therapeutics/Eli Lilly)
N/A
Report date: 2025/06/11 11:02:13
Base Information
Drug Namein vivo gene editing program targeting lipoprotein(a) (Verve Therapeutics/Eli Lilly)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerve Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyVerve Therapeutics Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A